Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 118

1.

Perceptions of Prophylactic Mastectomy in Korea.

Yoon HY, Shim JS, Lee JW.

Arch Plast Surg. 2016 Jan;43(1):53-8. doi: 10.5999/aps.2016.43.1.53. Epub 2016 Jan 15.

2.

A two-stage approach to genetic risk assessment in primary care.

Biswas S, Atienza P, Chipman J, Blackford AL, Arun B, Hughes K, Parmigiani G.

Breast Cancer Res Treat. 2016 Jan;155(2):375-83. doi: 10.1007/s10549-016-3686-2. Epub 2016 Jan 19.

PMID:
26786860
3.

Can the breast screening appointment be used to provide risk assessment and prevention advice?

Evans DG, Howell A.

Breast Cancer Res. 2015 Jul 9;17:84. doi: 10.1186/s13058-015-0595-y.

4.

BRCA Mutations Increase Fertility in Families at Hereditary Breast/Ovarian Cancer Risk.

Kwiatkowski F, Arbre M, Bidet Y, Laquet C, Uhrhammer N, Bignon YJ.

PLoS One. 2015 Jun 5;10(6):e0127363. doi: 10.1371/journal.pone.0127363. eCollection 2015.

5.

A risk prediction algorithm for ovarian cancer incorporating BRCA1, BRCA2, common alleles and other familial effects.

Jervis S, Song H, Lee A, Dicks E, Harrington P, Baynes C, Manchanda R, Easton DF, Jacobs I, Pharoah PP, Antoniou AC.

J Med Genet. 2015 Jul;52(7):465-75. doi: 10.1136/jmedgenet-2015-103077. Epub 2015 May 29.

6.

Recent Enhancements to the Genetic Risk Prediction Model BRCAPRO.

Mazzola E, Blackford A, Parmigiani G, Biswas S.

Cancer Inform. 2015 May 10;14(Suppl 2):147-57. doi: 10.4137/CIN.S17292. eCollection 2015. Review.

7.

Practical problems with clinical guidelines for breast cancer prevention based on remaining lifetime risk.

Quante AS, Whittemore AS, Shriver T, Hopper JL, Strauch K, Terry MB.

J Natl Cancer Inst. 2015 May 8;107(7). pii: djv124. doi: 10.1093/jnci/djv124. Print 2015 Jul.

8.

Genetics of breast cancer: a topic in evolution.

Shiovitz S, Korde LA.

Ann Oncol. 2015 Jul;26(7):1291-9. doi: 10.1093/annonc/mdv022. Epub 2015 Jan 20. Review.

PMID:
25605744
9.

Recurrent BRCA1 and BRCA2 mutations in Mexican women with breast cancer.

Torres-Mejía G, Royer R, Llacuachaqui M, Akbari MR, Giuliano AR, Martínez-Matsushita L, Angeles-Llerenas A, Ortega-Olvera C, Ziv E, Lazcano-Ponce E, Phelan CM, Narod SA.

Cancer Epidemiol Biomarkers Prev. 2015 Mar;24(3):498-505. doi: 10.1158/1055-9965.EPI-13-0980. Epub 2014 Nov 4.

PMID:
25371446
10.

Breast Cancer Risk - Genes, Environment and Clinics.

Fasching PA, Ekici AB, Adamietz BR, Wachter DL, Hein A, Bayer CM, Häberle L, Loehberg CR, Jud SM, Heusinger K, Rübner M, Rauh C, Bani MR, Lux MP, Schulz-Wendtland R, Hartmann A, Beckmann MW.

Geburtshilfe Frauenheilkd. 2011 Dec;71(12):1056-1066.

11.

Evaluation of the Dutch BRCA1/2 clinical genetic center referral criteria in an unselected early breast cancer population.

van den Broek AJ, de Ruiter K, van 't Veer LJ, Tollenaar RA, van Leeuwen FE, Verhoef S, Schmidt MK.

Eur J Hum Genet. 2015 May;23(5):588-95. doi: 10.1038/ejhg.2014.161. Epub 2014 Aug 20.

12.

Pathogenesis, prevention, diagnosis and treatment of breast cancer.

Shah R, Rosso K, Nathanson SD.

World J Clin Oncol. 2014 Aug 10;5(3):283-98. doi: 10.5306/wjco.v5.i3.283. Review.

13.

Breast cancer risk assessment using genetic variants and risk factors in a Singapore Chinese population.

Lee CP, Irwanto A, Salim A, Yuan JM, Liu J, Koh WP, Hartman M.

Breast Cancer Res. 2014 Jun 18;16(3):R64. doi: 10.1186/bcr3678.

14.

Current strategies for the prevention of breast cancer.

Advani P, Moreno-Aspitia A.

Breast Cancer (Dove Med Press). 2014 May 2;6:59-71. doi: 10.2147/BCTT.S39114. eCollection 2014. Review.

15.

Breast Cancer Risk - From Genetics to Molecular Understanding of Pathogenesis.

Fasching PA, Ekici AB, Wachter DL, Hein A, Bayer CM, Häberle L, Loehberg CR, Schneider M, Jud SM, Heusinger K, Rübner M, Rauh C, Bani MR, Lux MP, Schulz-Wendtland R, Hartmann A, Beckmann MW.

Geburtshilfe Frauenheilkd. 2013 Dec;73(12):1228-1235.

16.

Clinical prediction rules in practice: review of clinical guidelines and survey of GPs.

Plüddemann A, Wallace E, Bankhead C, Keogh C, Van der Windt D, Lasserson D, Galvin R, Moschetti I, Kearley K, O'Brien K, Sanders S, Mallett S, Malanda U, Thompson M, Fahey T, Stevens R.

Br J Gen Pract. 2014 Apr;64(621):e233-42. doi: 10.3399/bjgp14X677860. Review.

17.

Frailty Models for Familial Risk with Application to Breast Cancer.

Gorfine M, Hsu L, Parmigiani G.

J Am Stat Assoc. 2013 Dec 1;108(504):1205-1215.

18.

Cancer genetic counselor information needs for risk communication: a qualitative evaluation of interview transcripts.

Overby CL, Chung WK, Hripcsak G, Kukafka R.

J Pers Med. 2013;3(3). doi: 10.3390/jpm3030238.

19.

Reclassification of predictions for uncovering subgroup specific improvement.

Biswas S, Arun B, Parmigiani G.

Stat Med. 2014 May 20;33(11):1914-27. doi: 10.1002/sim.6077. Epub 2013 Dec 18.

20.

An assessment of existing models for individualized breast cancer risk estimation in a screening program in Spain.

Arrospide A, Forné C, Rué M, Torà N, Mar J, Baré M.

BMC Cancer. 2013 Dec 10;13:587. doi: 10.1186/1471-2407-13-587.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk